Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing ...

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

A molecular test identified patients with high-risk early lung cancer who significantly benefitted from adjuvant chemotherapy ...

If you don't feel hungry as much as you used to, or you are not wanting to eat as much food as you would usually, this could ...

Dr. M. Blair Marshall, thoracic oncology surgeon with the Jellison Cancer Institute, was the first physician on the Gulf Coast to use the technology ...